IMMUNOTHERAPY IN LEUKEMIA: EXPERIMENTAL AND CLINICAL APPROACHES = IMMUNOTHERAPIE DANS LA LEUCEMIE: TENTATIVES EXPERIMENTALES ET CLINIQUESMATHE G.1972; SER. HAEMATOL.; DANEM.; DA. 1972; VOL. 5; NO 5; PP. 66-86; BIBL. 4P.Serial Issue

Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen = Traitement de la leucémie murine par des anticorps monoclonaux dirigés contre un antigène de différenciation normalBADGER, C. C; BERNSTEIN, I. D.The Journal of experimental medicine. 1983, Vol 157, Num 3, pp 828-842, issn 0022-1007Article

Response of agranulocytosis to prolonged antithymocyte globulin therapyCHUDWIN, D. S; COWAN, M. J; GREENBERG, P. L et al.The Journal of pediatrics. 1983, Vol 103, Num 2, pp 223-227, issn 0022-3476Article

Current status and challenges of cytokine pharmacologyZIDEK, Z; ANZENBACHER, P; KMONICKOVA, E et al.British journal of pharmacology. 2009, Vol 157, Num 3, pp 342-361, issn 0007-1188, 20 p.Article

Immunotherapy concepts under investiaationKÜNDIG, T. M.Allergy (Copenhagen). 2011, Vol 66, pp 60-62, issn 0105-4538, 3 p., SUP95Conference Paper

Adjunct Immunotherapies for TuberculosisUHLIN, Michael; ANDERSSON, Jan; ZUMLA, Alimuddin et al.The Journal of infectious diseases. 2012, Vol 205, issn 0022-1899, S325-S334, SUP2Article

Immunoglobulin therapyFINLAYSON, J. S; TANKERSLEY, D. L.Lancet (British edition). 1991, Vol 338, Num 8771, pp 893-894, issn 0140-6736Article

Evolution des techniques de l'immunothérapie spécifique dans les allergies immédiates = Evolution of specific immunotherapy technics in proximate allergiesDRY, J.Bulletin de l'Académie nationale de médecine. 1983, Vol 167, Num 7, pp 731-735, issn 0001-4079Article

L'immunothérapie des cancers en 1983 = Immunotherapy of cancer in 1983MATHE, G; MISSET, J.-L.Gazette médicale de France (1969). 1983, Vol 90, Num 38, pp 3921-3926, issn 0016-5557Article

INTERFERONS AS ANTITUMOR AGENTSKIRCHNER H.1982; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1982; VOL. 103; NO 1; PP. 1-6; BIBL. 25 REF.Article

L'immunothérapie passe la quatrième avec les CAR T-cells : IMMUNO-ONCOLOGIE: Le combat biotech contre le cancerSIMON, Mathieu; SMITH, Julianne; VERNET, Agnès et al.Biofutur (Puteaux). 2014, Vol 352, pp 44-47, issn 0294-3506, 4 p.Article

Traitement médicamenteux du SIDA = Aids treatmentCOULAUD, J.-P.Gazette médicale de France (1969). 1989, Vol 96, Num 15, issn 0016-5557, 49Article

Immunotherapy with reptidesLARCHE, M.European annals of allergy and clinical immunology. 2006, Vol 38, Num 7, pp 240-243, issn 1764-1489, 4 p.Conference Paper

Immune monitoring of tumor development after renal transplantationSVEN ARVID BIRKELAND.Cancer. 1985, Vol 55, Num 5, pp 988-994, issn 0008-543XArticle

New approaches to the immunotherapy of cancerTOPALIAN, S. L; ROSENBERG, S. A.Natural immunity and cell growth regulation. 1988, Vol 7, Num 3, issn 0254-7600, 169Article

L'immunothérapie homoépathique = Immunotherapy in homeopathyJENAER, M; MARICHAL, B.L' Homéopathie française (Paris. 1912). 1988, Vol 76, Num 5, pp 281-299, issn 0018-4225Article

Biological response modifiers for the therapy of cancerHERBERMAN, R. B.Annals of allergy. 1985, Vol 54, Num 5, pp 376-381, issn 0003-4738Article

IMMUNTHERAPEUTISCHE UNTERSUCHUNGEN MIT VERBRENNUNGSTOXIN AM MODELL DER MAUS = ETUDES IMMUNOTHERAPEUTIQUES CHEZ LA SOURIS AVEC UN MODELE EXPERIMENTAL UTILISANT UNE NOUVELLE TOXINE DE BRULURESTAEDTLER K; ALLGOEWER M; CUENI LB et al.1972; RES. EXPER. MED.; GERM.; DA. 1972; VOL. 158; NO 1; PP. 34-42; ABS. ANGL.; BIBL. 12 REF.Serial Issue

Neurotoxines ophidiennes = Neurotoxins from snake venomLARRECHE, S; MION, G; CLAPSON, P et al.Annales françaises d'anesthésie et de réanimation. 2008, Vol 27, Num 4, pp 310-316, issn 0750-7658, 7 p.Article

Pharmakoprophylaxe und Begleitmedikation bei spezifischer Immuntherapie : Spezifische Immuntherapie = Pharmacoprophylaxis and co-medications in allergen-specific immunotherapy : Specific immunotherapyWEDI, B; RUEFF, F.Der Hautarzt. 2011, Vol 62, Num 9, issn 0017-8470, 663-670 [6 p.]Article

HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosisRIBEIRO, Alice M; BOCCA, Anamelia L; AMARAL, André C et al.Vaccine. 2010, Vol 28, Num 6, pp 1528-1534, issn 0264-410X, 7 p.Article

GSK's antigen-specific cancer immunotherapy programme : Pilot results leading to Phase III clinical developmentBRICHARD, Vincent G; LEJEUNE, Diane.Vaccine. Supplement. 2007, Vol 25, Num 2, issn 1359-5938, B61-B71Article

Mechanisms of immunotherapyTILL, Stephen J; FRANCIS, James N; NOURI-ARIA, Kayhan et al.Journal of allergy and clinical immunology. 2004, Vol 113, Num 6, pp 1025-1034, issn 0091-6749, 10 p.Article

Pythium insidiosum: An overviewGAASTRA, Wim; LIPMAN, Len J. A; DE COCK, Arthur W. A. M et al.Veterinary microbiology (Amsterdam). 2010, Vol 146, Num 1-2, pp 1-16, issn 0378-1135, 16 p.Article

Pankomab : a potent new generation anti-tumour MUC1 antibodyDANIELCZYK, Antje; STAHN, Renate; FAULSTICH, Dorian et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 11, pp 1337-1347, issn 0340-7004, 11 p.Article